PCR Molecular Diagnostics Market 2021: Classification, Application & Specification, Industry Overview, Top Key Regions Analysis and Profiles Overview 2028 | Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Takara Bio, Inc.,

PCR are most widely used diagnostic tests for detecting pathogens, including viruses. It Is considered as one of the best tests to identify the COVID 19 virus in the human body. PCR Molecular Diagnostics are used to identify symptomatic or asymptomatic SARS-CoV-2 carriers and is safe and accurate as they have a high clinical sensitivity and avoid false-negative results. Moreover, rising technological advancement and growing public awareness of preventive care are propelling the market growth. Though COVID 19 has a major impact on the medical industry, the PCR Molecular Diagnostics market is on a positive trend.

The rising prevalence of cancer and infectious diseases is also a major factor that drives PCR molecular diagnostics market. The Infectious Diseases Society of America has stated that every year there is a probability of new, potentially dangerous bacteria, viruses, fungi such as severe acute respiratory syndrome (SARS).

Market Overview

The PCR Molecular Diagnostics market is expected to grow with an estimated CAGR of +4%, over the forecast period.

The report is updated with the impact of the currently ongoing COVID-19 pandemic. The pandemic has dynamically affected key market segments and changed the growth pattern and demands in the PCR Molecular Diagnostics market. The report covers an in-depth analysis of these changes and provides an accurate estimate of the market growth forecast after the impact of the pandemic.

Request for a sample report here @  https://www.reportconsultant.com/request_sample.php?id=90820  

Some of the key players operating in the PCR Molecular Diagnostics market are Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Takara Bio, Inc., Qiagen N.V, etc.

Recent Developments

In March 2020, Abbott has received emergency use authorization (EUA) from the FDA for the product m2000 Real-Time System for identification of SARS-CoV-2. The platform uses polymerase chain reaction (PCR) technology, which amplifies a single piece (or few copies of a piece) of DNA to quickly and accurately diagnose a patient. The m2000 is currently used in labs around the world.

In April 2021, Thermo Fisher Scientific Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit. The Amplitude Solution enables clinical and public health laboratories to scale gold standard PCR testing and process up to 8,000 samples in a single day with minimal staffing resources and a secured supply of kits, reagents and consumables to meet their testing needs.

Scope of the Report

PCR, or the polymerase chain reaction, is a chemical reaction, which is considered to be a molecular technique that is used to amplify the DNA sequences. Short DNA sequences called primers are used to amplify the selected part of the genome.

It involves three steps denaturation, Annealing, extension, during which the temperature is raised and lowered which helps the DNA replication enzyme to copy the target DNA sequence, this helps to produce billions of target/desired sequences in few hours.

Market segmentation:
This report segments the market on the basis of by type are:

Instrument
Reagents
Consumables
Software

On the basis by application, the market is segmented into:

Infectious Disease Testing
Oncology Testing
Other Applications

Key Market Trends

The Oncology Testing Segment is Expected to Grow Over the Forecast Period

Polymer Chain Reaction (PCR) is widely used in diagnostics of oncology. Real-time PCR technology is best used for cancer diagnostics. In addition to this, there are several PCR techniques that help in cancer diagnosis and prognosis. In Jan 2020, a group of scientists in cancer research during a Bio-Rad workshop at the Precision Medicine World Conference (PMWC) in Santa Clara, California, has showcased that the Integrated Use of Next-Generation Sequencing and Droplet Digital PCR (ddPCR) in Cancer Monitoring in which they have concluded that droplet digital PCR (ddPCR) technology quantifies genetic material from tumor cells that have been entered to the bloodstream through a liquid biopsy approach. Using droplet digital PCR (ddPCR), 1,000 or even 10,000 wild-type copies with cancer-associated mutations can be detected within a few days. This data gives insights regarding when to add new therapies or discontinue existing treatments that are not working with this data valuable for clinicians.

Along with that, the companies are merging, engaging in partnerships and acquisitions to increase their manufacturing capacities, improve their product portfolio and to provide a competitive diversity. For instance, In September 2020, Qiagen announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for USD 248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. The above conditions show that the PCR Molecular Diagnostics market is expected to have a promising growth rate over the forecast period.

The report is mainly segmented into several key regions, with sales, revenue, market share, and growth rate in these regions, covering:

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Enquiry Before Buying: https://www.reportconsultant.com/enquiry_before_buying.php?id=90820

Table of Contents: -

1. Global PCR Molecular Diagnostics Market Overview
2. Global PCR Molecular Diagnostics Market Competitions by Manufacturers
3. Global PCR Molecular Diagnostics Capacities, Production, Revenue (Value) by Region
4. Global PCR Molecular Diagnostics Supply (Production), Consumption, Export, Import by Region
5. Global PCR Molecular Diagnostics Productions, Revenue (Value), Price Trend by Type
6. Global PCR Molecular Diagnostics Market Analyses by Application
7. Global PCR Molecular Diagnostics Manufacturers Profiles/Analysis
8. PCR Molecular Diagnostics Manufacturing Cost Analysis
9. Industrial Chain, Sourcing Strategy and Downstream Buyers
10. Marketing Strategy Analyses, Distributors/Traders
11. Market Effect Factors Analysis
12. Global PCR Molecular Diagnostics Market Forecast
13. Research Findings and Conclusion
14. Appendixes

The research includes historic data from 2015 to 2021 and forecasts until 2028 which makes the report's an invaluable resource for industry executives, Marketing, Sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Note- At Report Consultant, our main forte is to custom make research reports as per your requirements. Do share your niche requirements, if any.

Contact us:
Riaana Singh
(Report Consultant)
sales@reportconsultant.com | www.reportconsultant.com

About Us:

Report Consultant – A worldwide pacesetter in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly by taking calculative risks leading to lucrative business in the ever-changing market. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies.

Our research reports will give you the most realistic and incomparable experience of revolutionary market solutions. We have effectively steered business all over the world through our market research reports with our predictive nature and are exceptionally positioned to lead digital transformations. Thus, we craft greater value for clients by presenting progressive opportunities in the global futuristic market.

This release was published on openPR.